Combination of minocycline and rifampicin against methicillin- and gentamicin-resistantStaphylococcus aureus
Open Access
- 1 May 1981
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 34 (5) , 559-563
- https://doi.org/10.1136/jcp.34.5.559
Abstract
Methicillin- and gentamicin-resistant Staphylococcus aureus may remain sensitive to minocycline and to rifampicin. A study of growth curves has shown that at inhibitory concentrations (0·4 μg/ml), minocycline prevents the development of mutants resistant to rifampicin.This publication has 38 references indexed in Scilit:
- Interaction between rifampicin and trimethoprimJournal of Antimicrobial Chemotherapy, 1979
- Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infectionJournal of Antimicrobial Chemotherapy, 1978
- Antagonistic interaction of rifampicin and trimethoprimJournal of Antimicrobial Chemotherapy, 1978
- GENTAMICIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1976
- Trimethoprim and rifampicin: in vitro activities separately and in combinationJournal of Antimicrobial Chemotherapy, 1975
- Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureusThe Journal of Infectious Diseases, 1975
- Evaluation of Different Antibiotic Actions Combined with RifampicinChemotherapy, 1975
- MinocyclineDrugs, 1975
- Analysis of the resistance mediated by several R-factors to Tetracycline and MinocyclineGenetics Research, 1972
- Bacteriologic Studies of Rifampin, a New Semisynthetic AntibioticThe Journal of Infectious Diseases, 1969